Terephthalic Acid

Terephthalic Acid

SCHEMBL6856959

O=C([O-])c1ccc(C(=O)[O-])cc1.O=C([O-])c1cccc(C(=O)[O-])c1.[Na+].[Na+].[Na+].[Na+]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Terephthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA2 P00918 18/20 0.68
CA4 P22748 1/20 0.68
CA1 P00915 17/20 0.58
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PARP1 P09874 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isophthalic Acid SCHEMBL106980 0.95 CA2 (0.67) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL9930796 0.92 CA2 (0.64) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL6280489 0.92 CA2 (0.64) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL161261 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL23035003 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL25202017 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL105996 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL23035004 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL6264265 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1
Isophthalic Acid SCHEMBL3684094 0.90 CA2 (0.59) CA2CA4CA1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3973015-B1 PROCESS FOR PREPARING A MIXTURE OF RECYCLED TEREPHTHALIC ACID AND ISOPHTHALIC ACID RITTEC UMWELTTECHNIK GMBH (DE) 2024-04-10 EP disclosed
EP-3973015-A1 PROCESS FOR PREPARING A MIXTURE OF RECYCLED TEREPHTHALIC ACID AND ISOPHTHALIC ACID RITTEC Umwelttechnik GmbH (DE) 2022-03-30 EP disclosed
WO-2022033735-A1 PROCESS FOR PREPARING A MIXTURE OF RECYCLED TEREPHTHALIC ACID AND ISOPHTHALIC ACID RITTEC UMWELTTECHNIK GMBH (DE) 2022-02-17 WO disclosed
EP-3267971-B1 PRODUCT AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS HENKEL AG & CO KGAA (DE) 2020-02-19 EP disclosed
EP-2173318-B1 USE OF STYLING AGENTS BASED ON AQUEOUS SILICONE DISPERSIONS FOR REMODELLABLE STYLING OF KERATIN FIBRES HENKEL AG & CO KGAA (DE) 2015-11-11 EP disclosed
US-20120171266-A1 COSMETIC COMPOSITIONS AND METHODS OF MAKING AND USING THE COMPOSITIONS KAO USA INC. (US) 2012-07-05 US disclosed
US-6800302-B2 APPLYING TO KERATINOUS FIBERS A FORMULATION CONTAINING A COMPOUND CHOSEN FROM C3 TO C5 MONOSACCHARIDES SUBSTITUTED WITH ATLEAST ONE C1 TO C22 CARBON CHAIN, AND HEATING THE KERATINOUS FIBER FOR DURABLE NON-PERMANENT SHAPING L'OREAL S.A. (FR) 2004-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171266-A1 COSMETIC COMPOSITIONS AND METHODS OF MAKING AND USING THE COMPOSITIONS CUTA, MITF, TYR CA2 3768/4885CA4 3884/4885CA1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.